Photo from wikipedia
SMAD7 antisense oligonucleotides and sphingosine‐1‐phosphate receptor modulators are new oral agents that are being investigated as potential treatments for inflammatory bowel disease (Crohn's disease and ulcerative colitis). This article reports… Click to show full abstract
SMAD7 antisense oligonucleotides and sphingosine‐1‐phosphate receptor modulators are new oral agents that are being investigated as potential treatments for inflammatory bowel disease (Crohn's disease and ulcerative colitis). This article reports on some of the clinical trial outcomes so far.
Keywords:
bowel disease;
inflammatory bowel;
targets inflammatory;
therapeutic targets;
disease;
novel therapeutic
Journal Title: Prescriber
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prescriber
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!